HAEM5:Juvenile xanthogranuloma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Greg.Corboy1 (talk | contribs) m →Clinical Features: Greg Corboy editing initial page |
Greg.Corboy1 (talk | contribs) m Greg Corboy editing page |
||
| Line 44: | Line 44: | ||
==Epidemiology / Prevalence== | ==Epidemiology / Prevalence== | ||
Juvenile Xanthogranuloma is a rare histiocytic neoplasm comprising | Juvenile Xanthogranuloma is a rare histiocytic neoplasm comprising approximately 0.5% of all pediatric tumors, which is seldom seen in in adults. 20-35% cases are congenital, showing male predilection. Predominantly (>70%) cases arise during the first year of life. | ||
==Clinical Features== | ==Clinical Features== | ||
JXG lesions are generally asymptomatic; their appearance is typically different in adult and paediatric settings. Infants may present with ≥1 cutaneous, pale yellow-tan, dome-shaped papulonodular lesions. Approximately 5% of patients present with multiple lesions. Typically lesions begin as raised, pink to dark-brown lesions that may become less elevated over time. Spontaneous resolution of some lesions, leaving residual scarring or wrinkling, may occur after months or years. A clinical subtype of JXG called benign cephalic histiocytosis | JXG lesions are generally asymptomatic; their appearance is typically different in adult and paediatric settings. Infants may present with ≥1 cutaneous, pale yellow-tan, dome-shaped papulonodular lesions. Approximately 5% of patients present with multiple lesions. Typically lesions begin as raised, pink to dark-brown lesions that may become less elevated over time. Spontaneous resolution of some lesions, leaving residual scarring or wrinkling, may occur after months or years. A clinical subtype of JXG called benign cephalic histiocytosis presents with asymptomatic self-healing papular lesions involving the head and neck of young children. | ||
In adult JXG, lesions are often large, solitary and persistent; in this context Erdheim–Chester disease is an important differential diagnosis. | |||
JXG may occur in patients with neurofibromatosis type 1 and is also reported in Wiskott–Aldrich syndrome. | |||
{| class="wikitable" | {| class="wikitable" | ||
|'''Signs and Symptoms''' | |'''Signs and Symptoms''' | ||
| | |Initially asymptomatic | ||
≥1 cutaneous papulonodular lesions | ≥1 cutaneous papulonodular lesions | ||
| Line 57: | Line 61: | ||
|- | |- | ||
|'''Laboratory Findings''' | |'''Laboratory Findings''' | ||
|Abnormal | |Abnormal liver enzymes and metabolic tests | ||
Cytopenia | Cytopenia in cases with bone marrow involvement | ||
|} | |} | ||
| Line 381: | Line 385: | ||
==Familial Forms== | ==Familial Forms== | ||
JXG may occur in patients with neurofibromatosis type 1 or Wiskott–Aldrich syndrome. | |||
==Additional Information== | ==Additional Information== | ||